- Home
- PCQ vs BSX Comparison
PCQ vs BSX Comparison
Compare PCQ & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCQ
- BSX
- Stock Information
- Founded
- PCQ 2001
- BSX 1979
- Country
- PCQ United States
- BSX United States
- Employees
- PCQ N/A
- BSX N/A
- Industry
- PCQ Investment Managers
- BSX Medical/Dental Instruments
- Sector
- PCQ Finance
- BSX Health Care
- Exchange
- PCQ Nasdaq
- BSX Nasdaq
- Market Cap
- PCQ 163.2M
- BSX 157.6B
- IPO Year
- PCQ N/A
- BSX 1992
- Fundamental
- Price
- PCQ $8.79
- BSX $98.22
- Analyst Decision
- PCQ
- BSX Strong Buy
- Analyst Count
- PCQ 0
- BSX 22
- Target Price
- PCQ N/A
- BSX $118.91
- AVG Volume (30 Days)
- PCQ 69.6K
- BSX 8.1M
- Earning Date
- PCQ 01-01-0001
- BSX 10-22-2025
- Dividend Yield
- PCQ 4.63%
- BSX N/A
- EPS Growth
- PCQ N/A
- BSX 36.90
- EPS
- PCQ N/A
- BSX 1.68
- Revenue
- PCQ N/A
- BSX $18,494,000,000.00
- Revenue This Year
- PCQ N/A
- BSX $19.75
- Revenue Next Year
- PCQ N/A
- BSX $11.03
- P/E Ratio
- PCQ N/A
- BSX $58.57
- Revenue Growth
- PCQ N/A
- BSX 21.44
- 52 Week Low
- PCQ $8.19
- BSX $80.64
- 52 Week High
- PCQ $10.50
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- PCQ 84.55
- BSX 27.91
- Support Level
- PCQ $8.60
- BSX $104.24
- Resistance Level
- PCQ $8.70
- BSX $109.50
- Average True Range (ATR)
- PCQ 0.08
- BSX 2.15
- MACD
- PCQ 0.05
- BSX -1.04
- Stochastic Oscillator
- PCQ 91.95
- BSX 8.59
About PCQ PIMCO California Municipal Income Fund
PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal and California income tax. The fund makes investments in different sectors such as healthcare, property, education, Natural Gas, and others.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.